Federal appeals court to DEA: Reconsider marijuana’s Schedule 1 status
A federal appeals court in New York told the U.S. Drug Enforcement Administration (DEA) to “promptly” reconsider its…
News June 3
Latest In: dea
Congressional group urges feds to speed research into medical cannabis
A bipartisan group of 30 members of Congress on Tuesday sent a letter to U.S. Attorney General William Barr and…
News May 7
US lawmakers urge feds to expand approved marijuana growers for research
Fifteen U.S. House lawmakers urged the heads of the Department of Justice and the Drug Enforcement Administration to…
News October 2
DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access
The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that…
News September 27
Feds grant UC San Diego cannabis import license for product from Canada’s Tilray
In a rare move, the U.S. Drug Enforcement Administration approved the importation of marijuana extracts from Canada for…
News September 18
DEA to up amount of medical cannabis grown for federal research
The Drug Enforcement Administration took steps to dramatically increase the amount of cannabis that can legally be grown in…
News August 21
FDA approves cannabis-derived medicine; DEA must weigh in
The U.S. Food and Drug Administration has approved a CBD drug - a landmark decision that will trigger…
News June 25
US senators urge Justice Department to quit blocking marijuana research
One of the ways U.S. Attorney General Jeff Sessions is standing in the way of cannabis industry progress…
News April 13
Is CBD a drug? DEA hemp battle gets February court date
A long-awaited legal challenge targeting federal drug authorities who call CBD a controlled substance will be heard in…
News December 6Featured
1
Latest Sponsored
